ClinVar Genomic variation as it relates to human health
NM_198904.4(GABRG2):c.1140G>A (p.Met380Ile)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_198904.4(GABRG2):c.1140G>A (p.Met380Ile)
Variation ID: 521624 Accession: VCV000521624.2
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 5q34 5: 162151741 (GRCh38) [ NCBI UCSC ] 5: 161578747 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Apr 15, 2018 Dec 11, 2022 Apr 28, 2017 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_198904.4:c.1140G>A MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_944494.1:p.Met380Ile missense NM_000816.3:c.1129-1352G>A intron variant NM_001375339.1:c.1131G>A NP_001362268.1:p.Met377Ile missense NM_001375340.1:c.934G>A NP_001362269.1:p.Val312Ile missense NM_001375341.1:c.1137G>A NP_001362270.1:p.Met379Ile missense NM_001375342.1:c.1126-1352G>A intron variant NM_001375343.1:c.1249-1352G>A intron variant NM_001375344.1:c.1179G>A NP_001362273.1:p.Met393Ile missense NM_001375345.1:c.1063-1352G>A intron variant NM_001375346.1:c.1074G>A NP_001362275.1:p.Met358Ile missense NM_001375347.1:c.1053G>A NP_001362276.1:p.Met351Ile missense NM_001375348.1:c.709-1352G>A intron variant NM_001375349.1:c.844-1352G>A intron variant NM_001375350.1:c.720G>A NP_001362279.1:p.Met240Ile missense NM_198903.2:c.1260G>A NP_944493.2:p.Met420Ile missense NC_000005.10:g.162151741G>A NC_000005.9:g.161578747G>A NG_009290.1:g.89100G>A - Protein change
- M420I, M380I, M240I, M351I, M358I, M377I, M379I, M393I, V312I
- Other names
- -
- Canonical SPDI
- NC_000005.10:162151740:G:A
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
GABRG2 | Little evidence for dosage pathogenicity | No evidence available |
GRCh38 GRCh37 |
677 | 713 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Uncertain significance (1) |
criteria provided, single submitter
|
Apr 28, 2017 | RCV000622332.2 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Uncertain significance
(Apr 28, 2017)
|
criteria provided, single submitter
Method: clinical testing
|
Hereditary disease
Affected status: yes
Allele origin:
germline
|
Ambry Genetics
Accession: SCV000742293.2
First in ClinVar: Apr 15, 2018 Last updated: Dec 11, 2022 |
Comment:
Lines of evidence used in support of classification: UNCERTAIN: Alteration(s) of Uncertain Clinical Significance Detected
Clinical Features:
Seizures/Epilepsy (present) , Dermatologic (adult onset) (present) , Gastrointestinal (adult onset) (present) , Musculoskeletal/Structural (adult onset) (present) , Neurologic (child onset) (present)
Family history: yes
Sex: female
Segregation observed: yes
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Expanding the phenotypic spectrum of GABRG2 variants: a recurrent GABRG2 missense variant associated with a severe phenotype. | Zou F | Journal of neurogenetics | 2017 | PMID: 28460589 |
UniProt: the universal protein knowledgebase. | The UniProt Consortium | Nucleic acids research | 2017 | PMID: 27899622 |
De novo GABRG2 mutations associated with epileptic encephalopathies. | Shen D | Brain : a journal of neurology | 2017 | PMID: 27864268 |
Molecular Pathogenic Basis for GABRG2 Mutations Associated With a Spectrum of Epilepsy Syndromes, From Generalized Absence Epilepsy to Dravet Syndrome. | Kang JQ | JAMA neurology | 2016 | PMID: 27367160 |
Differential molecular and behavioural alterations in mouse models of GABRG2 haploinsufficiency versus dominant negative mutations associated with human epilepsy. | Warner TA | Human molecular genetics | 2016 | PMID: 27340224 |
Novel GABRG2 mutations cause familial febrile seizures. | Boillot M | Neurology. Genetics | 2015 | PMID: 27066572 |
Rare variants in γ-aminobutyric acid type A receptor genes in rolandic epilepsy and related syndromes. | Reinthaler EM | Annals of neurology | 2015 | PMID: 25726841 |
Association of nonsense mutation in GABRG2 with abnormal trafficking of GABAA receptors in severe epilepsy. | Ishii A | Epilepsy research | 2014 | PMID: 24480790 |
A novel GABRG2 mutation, p.R136*, in a family with GEFS+ and extended phenotypes. | Johnston AJ | Neurobiology of disease | 2014 | PMID: 24407264 |
GABA(A) receptor alpha1 subunit mutation A322D associated with autosomal dominant juvenile myoclonic epilepsy reduces the expression and alters the composition of wild type GABA(A) receptors. | Ding L | The Journal of biological chemistry | 2010 | PMID: 20551311 |
Mutational analysis of GABRG2 in a Japanese cohort with childhood epilepsies. | Shi X | Journal of human genetics | 2010 | PMID: 20485450 |
A novel GABRG2 mutation associated with febrile seizures. | Audenaert D | Neurology | 2006 | PMID: 16924025 |
Childhood absence epilepsy and febrile seizures: a family with a GABA(A) receptor mutation. | Marini C | Brain : a journal of neurology | 2003 | PMID: 12477709 |
Truncation of the GABA(A)-receptor gamma2 subunit in a family with generalized epilepsy with febrile seizures plus. | Harkin LA | American journal of human genetics | 2002 | PMID: 11748509 |
Mutant GABA(A) receptor gamma2-subunit in childhood absence epilepsy and febrile seizures. | Wallace RH | Nature genetics | 2001 | PMID: 11326275 |
First genetic evidence of GABA(A) receptor dysfunction in epilepsy: a mutation in the gamma2-subunit gene. | Baulac S | Nature genetics | 2001 | PMID: 11326274 |
click to load more click to collapse |
Text-mined citations for rs1554101092 ...
HelpRecord last updated Dec 11, 2022
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.